Your Health Insurer Shouldn’t Dictate Treatments, Docs Say
As cost controls tighten, doctors and AI are pressing to restore clinician-led care. Investors are watching insurers’...
Identify compelling low-cost index funds for retirement by evaluating tracking error, fees, and diversification. Build a lineup aligned with long-term goals.
27,243 articlesAs cost controls tighten, doctors and AI are pressing to restore clinician-led care. Investors are watching insurers’...
Altria sits around $73 with a near-6% yield, yet a from 52-week low: glaring risk and consumer softness raise questio...
A high-profile Arkansas event sparked financial ripples as sponsors and donors paused amid controversy. This article ...
Crypto markets have faced a rough patch, but history guide patterns offer clues. This what investors can watch, plus ...
The latest CPI data gave a calm surface, but the big questions remain. Wednesday's report didn't solve the inflation ...
NUKZ is in focus as two pivotal drivers could redefine its trajectory: big-hyperscaler nuclear agreements and the rol...
Bitcoin hovers near $70,000 as Iran-driven energy volatility cools and policy expectations shift, setting up a pivota...
A sharp slide in South Korea's equities market sparks a broader risk-off wave, with Bitcoin and other crypto assets w...
The United States launched strikes on Iranian targets after an attack that killed U.S. troops in Jordan, while Tehran...
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
The financial sector kicks off 2026 with its sharpest early-year drop in a decade. Analysts say high-ROE, low-P/E scr...
When Berkshire Hathaway's Greg Abel shifts course, investors sit up. This piece breaks down why he trimmed Amazon and...